Skip to main content

Table 3 Study drugs administration details

From: Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients

Total chemotherapy cycles administered

238

Total chemotherapy + celecoxib cycles administered

196

Chemotherapy + celecoxib cycles per patient, median (range)

3 (1-10)

Reason for treatment withdrawal

 

   Patient's refusal

5 (11.1)°

   Toxicity

4 (8.9)°

   Progression of disease

28 (62.2)

   Patient's decision after confirmation of response

8 (17.8)*

  1. °See Table 4 for details
  2. * All patients submitted to ≥ 6 cycles of treatment.